Table 3.
Biomarker/Index | AUC | 95% CI | P | |
---|---|---|---|---|
HC vs. SS | LDH | 0.7431 | 0.6161–0.8701 | 0.0009 |
ACE | 0.8190 | 0.7248–0.9131 | < 0.0001 | |
Fibrinogen | 0.7780 | 0.6358–0.9201 | 0.0014 | |
NLR | 0.7382 | 0.6243–0.8521 | 0.0011 | |
PLR | 0.7532 | 0.6379–0.8685 | 0.0005 | |
LMR | 0.767 | 0.6449–0.8891 | 0.0003 | |
SII | 0.7338 | 0.6138–0.8537 | 0.0014 | |
SIRI | 0.7377 | 0.6108–0.8646 | 0.0014 | |
AISI | 0.7143 | 0.5818–0.8468 | 0.0039 | |
HC vs. PMF | LDH | 0.8374 | 0.7291–0.9457 | < 0.0001 |
ACE | 0.9142 | 0.8446–0.9838 | < 0.0001 | |
Fibrinogen | 0.7870 | 0.6466–0.9275 | 0.0018 | |
NLR | 0.8281 | 0.7234–0.9328 | < 0.0001 | |
PLR | 0.8100 | 0.6916–0.9285 | < 0.0001 | |
LMR | 0.8535 | 0.7531–0.9539 | < 0.0001 | |
SII | 0.8054 | 0.6922–0.9185 | < 0.0001 | |
SIRI | 0.8138 | 0.7060–0.9215 | < 0.0001 | |
AISI | 0.8059 | 0.6951–0.9167 | 0.0001 | |
SS vs. PMF | LDH | 0.6811 | 0.5689–0.07933 | 0.0028 |
ACE | 0.5747 | 0.4570–0.6924 | 0.2258 | |
Fibrinogen | 0.6179 | 0.4713–0.7645 | 0.1072 | |
NLR | 0.5595 | 0.4438–0.6753 | 0.3254 | |
PLR | 0.5385 | 0.4224–0.6546 | 0.5251 | |
LMR | 0.6277 | 0.5133–0.7422 | 0.0348 | |
SII | 0.5733 | 0.4574–0.6891 | 0.2261 | |
SIRI | 0.6264 | 0.5102–0.7426 | 0.0368 | |
AISI | 0.6227 | 0.5075–0.7379 | 0.0426 |
AUC, area under the ROC curve; 95% CI, 95% confidence interval; LDH lactate dehydrogenase; ACE angiotensin convertase enzyme; NLR (neutrophil/lymphocyte ratio), PLR (platelet/lymphocyte ratio), LMR (lymphocyte/monocyte ratio), SII (neutrophil x platelet/lymphocyte ratio), SIRI (neutrophil x monocyte/lymphocyte ratio) and AISI (neutrophil x monocyte x platelet/lymphocyte ratio). 95% CI, 95% confidence interval; P, p value.